Synthesis and biological evaluation of novel 1-Alkyl-tryptophan analogs as potential antitumor agents

Molecules

Volumn 14, Issue 12, 2009, Pages 5339-5348

  Sun, Ting ^a   Li, Zhao Long ^b   Tian, Hua ^c   Wang, Shih Chen ^a   Cai, Jiong ^a  

^a PEKING UNION MEDICAL COLLEGE   (China)

^b TSINGHUA UNIVERSITY   (China)

^c SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Cytotoxicity; MTT; Tryptophan analogs

Indexed keywords

ANTINEOPLASTIC AGENT; DRUG DERIVATIVE; TRYPTOPHAN;

ARTICLE; DRUG SCREENING; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; SYNTHESIS; TUMOR CELL LINE;

ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; DRUG SCREENING ASSAYS, ANTITUMOR; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; TRYPTOPHAN;

EID: 73849151777     PISSN: None     EISSN: 14203049     Source Type: Journal    
DOI: 10.3390/molecules14125339     Document Type: Article

References (21)

1. Penedo, L.A.; Oliveira-Silva, P.; Gonzalez, E.M.; Maciel, R.; Jurgilas, P.B.; Melibeu Ada, C.; Campello-Costa, P.; Serfaty, C.A. Nutritional tryptophan restriction impairs plasticity of retinotectal axons during the critical period. Exp. Neurol. 2009, 217, 108-115.
2. Isselbacher, K.J. Sugar and amino acid transport by cells in culture-differences between normal and malignant cells. N. Engl. J. Med. 1972, 286, 929-933.
3. Petersen, J.L.; Hickman-Miller, H.D.; McIlhaney, M.M.; Vargas, S.E.; Purcell, A.W.; Hildebrand, W.H.; Solheim, J.C. A charged amino acid residue in the transmembrane/cytoplasmic region of tapasin influences MHC class I assembly and maturation. J. Immunol. 2005, 174, 962-969.
4. Jing, Y.; Cui, D.; Bao, F.; Hu, Z.; Qin, Z.; Hu, Y. Tryptophan deficiency affects organ growth by retarding cell expansion in Arabidopsis. Plant J. 2009, 57, 511-521.
5. Sibilia, V.; Pagani, F.; Lattuada, N.; Greco, A.; Guidobono, F. Linking chronic tryptophan deficiency with impaired bone metabolism and reduced bone accrual in growing rats. J. Cell Biochem. 2009, 107, 890-898.
6. Katz, J.B.; Muller, A.J.; Prendergast, G.C. Indoleamine 2,3-dioxygenase in T-cell tolerance and tumoral immune escape. Immunol. Rev. 2008, 222, 206-221.
7. Kobayashi, K.; Ohnishi, A.; Promsuk, J.; Shimizu, S.; Kanai, Y.; Shiokawa, Y.; Nagane, M. Enhanced tumor growth elicited by L-type amino acid transporter 1 in human malignant glioma cells. Neurosurgery 2008, 62, 493-503, discussion 503-504.
8. Shennan, D.B.; Thomson, J.; Barber, M.C.; Travers, M.T. Functional and molecular characteristics of system L in human breast cancer cells. Biochim. Biophys. Acta 2003, 1611, 81-90.
9. Taylor, M.W.; Feng, G.S. Relationship between interferon-gamma, indoleamine 2,3-dioxygenase, and tryptophan catabolism. FASEB J. 1991, 5, 2516-2522.
10. Hou, D.Y.; Muller, A.J.; Sharma, M.D.; DuHadaway, J.; Banerjee, T.; Johnson, M.; Mellor, A.L.; Prendergast, G.C.; Munn, D.H. Inhibition of indoleamine 2,3-dioxygenase in dendritic cells by stereoisomers of 1-methyl-tryptophan correlates with antitumor responses. Cancer Res. 2007, 67, 792-801.
11. Sundin, A.; Garske, U.; Orlefors, H. Nuclear imaging of neuroendocrine tumours. Best Pract. Res. Clin. Endocrinol. Metab. 2007, 21, 69-85.
12. Thomas, S.R.; Mohr, D.; Stocker, R. Nitric oxide inhibits indoleamine 2,3-dioxygenase activity in interferon-gamma primed mononuclear phagocytes. J. Biol. Chem. 1994, 269, 14457-14464.
13. Marchand, P.; Le Borgne, M.; Na, Y.M.; Pagniez, F.; Abdala, H.; Le Baut, G.; Le Pape, P. Synthesis and antileishmanial activity of 3-(alpha-azolylbenzyl) indoles. J. Enzyme Inhib. Med. Chem. 2002, 17, 353-358.
14. Kong, J.R.; Cho, C.W.; Krische, M.J. Hydrogen-mediated reductive coupling of conjugated alkynes with ethyl (N-Sulfinyl)iminoacetates: synthesis of unnatural alpha-amino acids via rhodium-catalyzed C-C bond forming hydrogenation. J. Am. Chem. Soc. 2005, 127, 11269-11276.
15. Harding, W.W.; Hodge, M.; Wang, Z.; Woolverton, W.L.; Parrish, D.; Deschamps, J.R.; Prisinzano, T.E. Enantioselective synthesis of (2R,3R)- and (2S,3S)-2-[(3-chlorophenyl)-(2-methoxyphenoxy)methyl]morpholine. Tetrahedron Asymmetry 2005, 16, 2249-2256.
16. Kundrat, M.D.; Autschbach, J. Computational modeling of the optical rotation of amino acids: A new look at an old rule for pH dependence of optical rotation. J. Am. Chem. Soc. 2008, 130, 4404-4414.
17. Munn, D.H.; Mellor, A.L. Indoleamine 2,3-dioxygenase and tumor-induced tolerance. J. Clin. Invest. 2007, 117, 1147-1154.
18. Inaba, T.; Ino, K.; Kajiyama, H.; Yamamoto, E.; Shibata, K.; Nawa, A.; Nagasaka, T.; Akimoto, H.; Takikawa, O.; Kikkawa, F. Role of the immunosuppressive enzyme indoleamine 2,3-dioxygenase in the progression of ovarian carcinoma. Gynecol. Oncol. 2009, 115, 185-192.
19. Giese, C.; Lepthien, S.; Metzner, L.; Brandsch, M.; Budisa, N.; Lilie, H., Intracellular uptake and inhibitory activity of aromatic fluorinated amino acids in human breast cancer cells. ChemMedChem 2008, 3, 1449-1456.
20. Katayama, H.; Brinkley, W.R.; Sen, S. The Aurora kinases: Role in cell transformation and tumorigenesis. Cancer Metastasis Rev. 2003, 22, 451-464.
21. Juhasz, C.; Muzik, O.; Lu, X.; Jahania, M.S.; Soubani, A.O.; Khalaf, M.; Peng, F.; Mangner, T.J.; Chakraborty, P.K.; Chugani, D.C. Quantification of tryptophan transport and metabolism in lung tumors using PET. J. Nucl. Med. 2009, 50, 356-363.